Ignite Creation Date:
2024-10-26 @ 3:41 PM
Last Modification Date:
2024-10-26 @ 3:41 PM
Study NCT ID:
NCT06617910
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
None
First Post:
2024-09-22
Brief Title:
Stereotactic Radiotherapy for Sinonasal Malignancy
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Treatment Outcomes and Dosimetric Analysis Comparison Between CyberKnife and VMAT Based Methods of Stereotactic Radiotherapy for Sinonasal Malignancy
Status:
ACTIVE_NOT_RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Sinonasal Tumors are a rare type of head and neck tumor accounting for approximately 3 of head and neck cancers Treatment primarily involves surgical intervention with radiation therapy as an adjunct Due to the tumor39s anatomical location near critical structures such as the eyes optic nerves optic chiasm brainstem and oral cavity if the tumor cannot be completely resected postoperative radiation therapy is often necessary Given the complexity of the tumor39s anatomical position subsequent radiation therapy planning becomes more challenging as it must balance tumor control and organ preservation This study retrospectively analyzes patients with sinonasal tumors who received stereotactic radiosurgery CyberKnife at our hospital comparing the dosimetric advantages treatment efficacy survival analysis and side effects with those of volumetric modulated arc therapy VMAT
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None